These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34905930)

  • 1. Somatostatin receptor PET beyond the neuroendocrine tumors of the gastrointestinal tract - the review of literature.
    Zogala D
    Klin Onkol; 2021; 34(4):291-299. PubMed ID: 34905930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET/Computed Tomography in Neuroendocrine Tumor: Value to Patient Management and Survival Outcomes.
    Shamim SA; Kumar A; Kumar R
    PET Clin; 2015 Jul; 10(3):411-21. PubMed ID: 26099675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-fluorodihydroxyphenylalanine in the diagnosis of neuroendocrine tumors.
    Minn H; Kemppainen J; Kauhanen S; Forsback S; Seppänen M
    PET Clin; 2014 Jan; 9(1):27-36. PubMed ID: 25029931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of 18F-fluorodeoxyglucose PET in the study of neuroendocrine tumors.
    Panagiotidis E; Bomanji J
    PET Clin; 2014 Jan; 9(1):43-55. PubMed ID: 25029933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-photon emission computed tomography tracers in the diagnostics of neuroendocrine tumors.
    Pepe G; Bombardieri E; Lorenzoni A; Chiti A
    PET Clin; 2014 Jan; 9(1):11-26. PubMed ID: 25029930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging of neuroendocrine tumors.
    Rufini V; Calcagni ML; Baum RP
    Semin Nucl Med; 2006 Jul; 36(3):228-47. PubMed ID: 16762613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radionuclide imaging of neurendocrine tumors: biological basis and diagnostic results].
    Genovese EA; Mallardo V; Rossi M; Vaccaro A; Raucci A; Della Vecchi N; Romano G; Califano T; Schillirò F
    Recenti Prog Med; 2013; 104(7-8):340-4. PubMed ID: 24042404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of (18) F-FDOPA PET/CT imaging in endocrinology.
    Santhanam P; Taïeb D
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):789-98. PubMed ID: 25056984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostics and treatment of neuroendocrine tumors of the digestive tract in the light of the present standards].
    Szczeblowska D
    Pol Merkur Lekarski; 2007 May; 22(131):437-41. PubMed ID: 17679390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical value of [18F]fluoro-dihydroxyphenylalanine positron emission tomography in primary diagnosis, staging, and restaging of neuroendocrine tumors.
    Kauhanen S; Seppänen M; Ovaska J; Minn H; Bergman J; Korsoff P; Salmela P; Saltevo J; Sane T; Välimäki M; Nuutila P
    Endocr Relat Cancer; 2009 Mar; 16(1):255-65. PubMed ID: 19088184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis.
    Treglia G; Castaldi P; Rindi G; Giordano A; Rufini V
    Endocrine; 2012 Aug; 42(1):80-7. PubMed ID: 22350660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pre- and intraoperative localization of neuroendocrine tumors].
    Adams S; Baum RP; Adams M; Wenisch H; Schumm-Draeger PM; Encke A; Usadel KH; Hör G
    Acta Med Austriaca; 1997; 24(2):81-6. PubMed ID: 9273812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular imaging of gastroenteropancreatic neuroendocrine tumors.
    Miederer M; Weber MM; Fottner C
    Gastroenterol Clin North Am; 2010 Dec; 39(4):923-35. PubMed ID: 21093764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Imaging of neuroendocrine tumors of the gastrointestinal tract : Value of (hybrid) imaging diagnostics in radiology].
    Ebner R; Rübenthaler J; Ricke J; Sheikh GT; Unterrainer LM; Auernhammer CJ; Spitzweg C; Brendel M; Schmid-Tannwald C; Cyran CC
    Radiologie (Heidelb); 2024 Jul; 64(7):553-558. PubMed ID: 38713221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrid Somatostatin Receptor PET/MRI of the Head and Neck.
    Keir G; Petrover D; Caravella C; Goenka A; Rini JN; Franceschi AM
    Radiographics; 2024 Oct; 44(10):e240020. PubMed ID: 39325659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours.
    Ambrosini V; Tomassetti P; Castellucci P; Campana D; Montini G; Rubello D; Nanni C; Rizzello A; Franchi R; Fanti S
    Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1431-8. PubMed ID: 18418596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of positron emission tomography in thyroid and neuroendocrine tumors.
    Treglia G; Kroiss AS; Piccardo A; Lococo F; Santhanam P; Imperiale A
    Minerva Endocrinol; 2018 Sep; 43(3):341-355. PubMed ID: 28949122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular imaging for neuroendocrine tumours.
    Antwi K; Nicolas G; Wild D; Christ E
    Swiss Med Wkly; 2019 Feb; 149():w20017. PubMed ID: 30852831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (18)F-DOPA PET/CT revealed synchronous neuroendocrine tumors in two sisters with MEN2A syndrome.
    Treglia G; Castaldi P; Rufini V
    Endocrine; 2013 Apr; 43(2):458-9. PubMed ID: 23229684
    [No Abstract]   [Full Text] [Related]  

  • 20. 18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type.
    Balogova S; Talbot JN; Nataf V; Michaud L; Huchet V; Kerrou K; Montravers F
    Eur J Nucl Med Mol Imaging; 2013 Jun; 40(6):943-66. PubMed ID: 23417499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.